Claritev Current Ratio 2019-2025 | CTEV
Claritev current ratio from 2019 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Claritev Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.19B | $0.18B | 1.02 |
| 2024-12-31 | $0.18B | $0.21B | 0.82 |
| 2024-09-30 | $0.21B | $0.20B | 1.05 |
| 2024-06-30 | $0.19B | $0.18B | 1.06 |
| 2024-03-31 | $0.19B | $0.19B | 0.98 |
| 2023-12-31 | $0.19B | $0.17B | 1.16 |
| 2023-09-30 | $0.21B | $0.17B | 1.23 |
| 2023-06-30 | $0.21B | $0.15B | 1.42 |
| 2023-03-31 | $0.37B | $0.16B | 2.39 |
| 2022-12-31 | $0.45B | $0.18B | 2.54 |
| 2022-09-30 | $0.53B | $0.23B | 2.30 |
| 2022-06-30 | $0.47B | $0.15B | 3.17 |
| 2022-03-31 | $0.46B | $0.20B | 2.25 |
| 2021-12-31 | $0.32B | $0.14B | 2.25 |
| 2021-09-30 | $0.31B | $0.17B | 1.83 |
| 2021-06-30 | $0.28B | $0.11B | 2.52 |
| 2021-03-31 | $0.21B | $0.22B | 0.98 |
| 2020-12-31 | $0.21B | $0.11B | 1.86 |
| 2020-09-30 | $0.00B | $0.01B | 0.38 |
| 2020-06-30 | $0.00B | $0.00B | 1.71 |
| 2020-03-31 | $0.00B | $0.00B | 9.65 |
| 2019-12-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.636B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.883B | 59.65 |
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.472B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Evolent Health (EVH) | United States | $1.162B | 99.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.175B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |